Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardiff Oncology (CRDF) Times Interest Earned (2017 - 2018)

Cardiff Oncology (CRDF) has disclosed Times Interest Earned for 7 consecutive years, with -$17687.4 as the latest value for Q4 2018.

  • Quarterly Times Interest Earned fell 10969.26% to -$17687.4 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was -$71089.2 through Sep 2019, down 20656.39% year-over-year, with the annual reading at -$9543.0 for FY2020, N/A changed from the prior year.
  • Times Interest Earned hit -$17687.4 in Q4 2018 for Cardiff Oncology, up from -$240956.8 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$10.11 in Q3 2014 to a low of -$240956.8 in Q3 2018.
  • Historically, Times Interest Earned has averaged -$20340.8 across 4 years, with a median of -$156.17 in 2017.
  • Biggest five-year swings in Times Interest Earned: skyrocketed 98.33% in 2014 and later plummeted 154188.07% in 2018.
  • Year by year, Times Interest Earned stood at -$10.11 in 2014, then crashed by 86.19% to -$18.82 in 2015, then tumbled by 749.16% to -$159.79 in 2017, then plummeted by 10969.26% to -$17687.4 in 2018.
  • Business Quant data shows Times Interest Earned for CRDF at -$17687.4 in Q4 2018, -$240956.8 in Q3 2018, and -$4799.6 in Q2 2018.